Alpha Tau Medical
PublicAlpha Tau Medical is now publicly traded
The data on this page reflects Alpha Tau Medical's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
PIPE
Apr 28, 2025
Total Funding Raised
$181.9M
Company Overview
Alpha Tau Medical (NAS: DRTS) is a clinical-stage oncology therapeutics company specializing in localized radiation therapy for solid tumors using its proprietary Alpha CaRT technology that leverages the unique properties of alpha particles.
Sector
Healthcare
AI Layer
Non-AI
Keywords
Alpha Tau Medical Comparables
Compare Alpha Tau Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BEBIG Medical GmbH | 71% | |
| Alpheus Medical | 63% | |
| PanTher Therapeutics | 61% |
Alpha Tau Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| PIPE | Apr 28, 2025 | ||||
| Reverse Merger | Mar 7, 2022 | ||||
| Series B | Jun 4, 2020 | ||||
| Series A | Sep 5, 2018 |
Alpha Tau Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Das & Co. | Series A |
| Happiness Capital | Series B |
| Grand Decade Developments | Reverse Merger |
| Medison Ventures | Series B, Series A |
| Medison Ventures | Series A, Series B |
| Shavit Capital | Series B, Series A |
| Regah Ventures | Reverse Merger |
Alpha Tau Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access